Several regulators (mammalian target of rapamycin, serum response factor, atrogin-1, myostatin, etc.)seem to modulate protein synthesis and degradation or transcription of muscle-specific genes during both sarcopenia and muscular dystrophy. The gene discussed is FBXO32; the disease is sarcopenia.